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OBJECTIVES
This paper aims at comparing cardiorespiratory 
functional capacity during exercise - represented by 
indicators of functional limitation, maximal oxygen uptake 
(VO2max), and anaerobic threshold – plus cardiopulmonary 
responses to maximal exercise in congestive heart failure 
(CHF) patients belonging to different age groups. 
METHODS 
Fifty-four CHF patients, stratiﬁ ed by age group, were 
evaluated as follows: group I – 30  to 39 years (n = 12); 
group II – 40 to 49 years (n = 18); group III – 50 to 59 
years (n = 17); and group IV – 60 years and above (n 
= 7). All patients underwent maximal cardiopulmonary 
exercise testing (CPET) on treadmills.  A single-factor 
analysis of variance (ANOVA) was performed to compare 
different age groups.
RESULTS 
No signiﬁ cant differences were found in maximal 
oxygen uptake and anaerobic threshold among the 
age groups, nor in maximal values for carbon dioxide 
production, oxygen pulse, respiratory exchange ratio, 
pulmonary ventilation, and ventilatory equivalents for 
oxygen and carbon dioxide. 
CONCLUSIONS
These ﬁ ndings suggest that cardiorespiratory functional 
capacity during exercise in patients with CHF, as well 
as cardiopulmonary variables at maximal exercise, may 
be similarly affected by the heart disease in all studied 
age groups. 
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Cardiopulmonary exercise testing is a non-invasive 
method to assess aerobic capacity in patients with heart 
failure, by determining maximal oxygen uptake (VO2max)
and anaerobic threshold1.
Maximal oxygen uptake (or peak oxygen uptake) values 
provide relevant information for the prognosis of these 
patients2, allowing identiﬁ cation of those who should 
be prioritized for heart transplantation3. These values, 
therefore, are essential for the appropriate selection of 
potential heart transplantation candidates. 
VO2max can also be used to classify functional ﬁ tness 
in patients with congestive heart failure (CHF). Franciosa 
et al5 divided patients into four groups according to 
VO2max values obtained by cardiopulmonary exercise 
testing on a cycle ergometer, evaluating 44 patients 
with ages ranging from 39 to 70, mean age 56. Weber 
et al6 also classiﬁ ed CHF patients according to maximal 
oxygen uptake values obtained by treadmill exercise tests, 
evaluating 62 patients with ages ranging from 19 to 79, 
mean age 52 years. In these studies, patients’ functional 
classiﬁ cation was performed regardless of age group.
Oxygen uptake at peak exercise and at anaerobic 
threshold decline with age7.
Inbar et al8 compared cardiopulmonary responses 
obtained during exercise for 1,424 healthy male subjects 
age 20 to 70, ﬁ nding, in addition to a decrease in maximal 
oxygen uptake and oxygen uptake at the anaerobic 
threshold, a decrease in maximal carbon dioxide 
production, heart rate, oxygen pulse, and pulmonary 
ventilation, plus a slight increase in maximal ventilatory 
equivalents for oxygen and carbon dioxide. They found no 
difference in maximal respiratory exchange ratio.  
Cardiopulmonary exercise testing can also be used 
to determine whether exertional dyspnea is caused by a 
cardiac or a ventilatory problem7,9-11. Nery et al9 compared 
cardiovascular and respiratory responses to exercise in 
patients with chronic obstructive pulmonary disease 
(COPD), mean age 57 years (43 to 63), and mitral 
valve disease, mean age 33.7 years (20 to 43). Cesar 
et al10 compared patients with COPD, mean age 65.5 
years (36 to 77) and CHF, mean age 44.4 years (29 to 
67). Therefore, these studies failed to compare patients 
belonging to the same age group.
Although variables measured by cardiopulmonary 
exercise testing in CHF patients are used for functional 
classiﬁ cation, such as criterion for heart transplantation, 
assessment of rehabilitation programs effects and 
determination of exertional dyspnea etiology7, studies 
evaluating these variable results in tests of patients of 
different age groups are lacking. This paper, therefore, 
aims at comparing indices of functional cardiorespiratory 
limitation, maximal oxygen uptake, and anaerobic 
threshold in different age groups, and also cardiopulmonary 
responses to maximal exercise in CHF patients.
METHODS
Fifty-four CHF patients - class I to IV according to the 
New York Heart Association - using angiotensin-converting 
enzyme (ACE) inhibitor, diuretics, digitalis, beta-blockers, 
amiodarone and/or nitrate in optimal dosages were 
evaluated. Patients were stratiﬁ ed by age group. 
Group I was composed of twelve patients, ages 
ranging from 30 to 39, mean age 35.2 (SD=2.9), nine 
male subjects and three female subjects, mean ejection 
fraction of 25.9% (SD=9.7). From the etiological point of 
view, seven patients were classiﬁ ed as having idiopathic 
cardiomyopathy, four as having chagasic cardiomyopathy, 
and one as having ischemic cardiomyopathy. Two patients 
were hypertensive, and one, diabetic. Ten patients were in 
sinus rhythm and two had a cardiac pacemaker. Regarding 
medications, eleven patients were using ACE inhibitors; 
eleven, loop diuretics; eight, aldosterone inhibitors; three, 
thiazide diuretics; eleven, digitalis; three, beta-blockers; 
three, amiodarone; one, nitrate; two, anticoagulants; and 
one, oral hypoglycemics.
Group II was composed of eighteen patients, ages 
ranging from 40 to 49, mean age 46.2 (SD=2.7), 
fourteen male subjects and four female subjects, mean 
ejection fraction of 23.9% (SD=9.9), eleven of whom 
were classified as having chagasic cardiomyopathy, 
four as having idiopathic cardiomyopathy, and three as 
having ischemic cardiomyopathy. Four patients were 
hypertensive. Fourteen patients were in sinus rhythm, two 
in atrial ﬁ brillation, and two had a cardiac pacemaker. 
Seventeen patients were using ACE inhibitors; seventeen, 
loop diuretics; thirteen, aldosterone inhibitors; four, 
thiazide diuretics; twelve, digitalis; ﬁ ve, beta-blockers; 
eleven, amiodarone, three, nitrate; four, anticoagulants; 
and two, antiplatelets. 
Group III consisted of seventeen patients, ages 
ranging from 50 to 59, mean age 54.1 (SD=3.0), 
thirteen male subjects and four female subjects, mean 
ejection fraction of 25.1% (SD=7.2), seven of whom 
were classiﬁ ed as having ischemic cardiomyopathy, 
ﬁ ve as having idiopathic cardiomyopathy, and ﬁ ve as 
having chagasic cardiomyopathy. Three patients were 
hypertensive, and four, diabetics. Fourteen patients were 
in sinus rhythm, two in atrial ﬁ brillation, and one had a 
cardiac pacemaker. Regarding medication, seventeen 
patients were using ACE inhibitors; ﬁ fteen, loop diuretics; 
thirteen, aldosterone inhibitors; four, thiazide diuretics; 
ﬁ fteen, digitalis; six, beta-blockers; ﬁ ve, amiodarone; two, 
nitrate; three, anticoagulants; four, antiplatelets; three, 
oral hypoglycemics; and two, insulin.
Group IV comprised seven patients, age 60 and above 
(60 to 74) mean age 67.0 (SD=4.2), six male subjects 
and one female subject, mean ejection fraction of 27.6% 
(SD=13.3), ﬁ ve of whom were classiﬁ ed as having 
idiopathic cardiomyopathy and two as having ischemic 
cardiomyopathy. Four patients were hypertensive, and 
one, diabetic. All seven patients were in sinus rhythm. 
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Also, all seven were using ACE inhibitors; six, loop 
diuretics; ﬁ ve, aldosterone inhibitors; three, digitalis; 
three, beta-blockers; three, amiodarone; three, nitrate; 
and ﬁ ve, antiplatelets.
This study was approved by the Institutional Research 
Ethics Committee of the University. After reading a 
letter informing about the study, all patients signed an 
informed consent. 
The four groups of cardiac patients underwent 
maximal cardiopulmonary exercise testing on a 
treadmill Model 2000, Sensor Medics - USA, following 
the protocol proposed by Weber et al11,12. The criterion 
used to determine maximal exercise was that an 
increase in workload did not lead to an oxygen uptake 
exceeding 150 ml/min, attaining a plateau, so that 
VO2max was reached
13.
Cardiopulmonary variables were determined during a 
three-minute rest, throughout the exercise and up to the 
third minute of recovery. The patient breathed room air, 
and the expired air was analyzed by a Cardiopulmonary 
Exercise Testing Instrument (SensorMedics Vmax 29C 
– USA), which measured and analyzed the airﬂ ow and 
oxygen and carbon dioxide fractions breath-by-breath, 
calculating oxygen uptake, carbon dioxide production, 
and pulmonary ventilation. 
Functional cardiorespiratory limitation indices during 
exercise, maximal oxygen uptake (VO2 max) and anaerobic 
threshold (AT)7 by gas exchange were determined, 
expressed as milliliters per kilogram of body weight 
(ml/kg/min). The following cardiopulmonary variables 
during maximal exercise were also determined: oxygen
uptake (VO2max l/min) and carbon dioxide production 
(VCO2max l/min), respiratory exchange ratio (Rmax), heart 
rate (HRmax), oxygen pulse (O2 pulse max), pulmonary 
Table I – Descriptive measures and analysis of variance results for body weight, height and body mass index 
(BMI) for groups I (30 to 39 years), II (40 to 49 years), III (50 to 59 years) and IV (≥ 60 years) of patients 
with congestive heart failure
Body weight (kg) Height (cm) BMI (kg/m2)
Mean Standard deviation Mean Standard deviation Mean Standard deviation
Group I (n = 12) 64.1 16.1 165.2 9.2 23.4 5.0
Group II (n = 18) 67.8 14.6 165.5 10.1 24.7 4.6
Group III (n = 17) 67.8 12.8 163.4 9.0 25.2 3.1
Group IV (n = 7) 73.4 13.6 163.8 5.4 27.2 3.8
p = 0.601 p = 0.895 p = 0.288
Table II – Descriptive measures and analysis of variance results for maximal oxygen uptake (VO2max) and 
anaerobic threshold (AT) for groups I (30 to 39 years), II (40 to 49 years), III (50 to 59 years), and IV (≥ 60 
years) of  patients with congestive heart failure
VO2máx (ml/kg/min) AT (ml/kg/min)
Mean
Standard
deviation
Minimum
value
Maximum
value
Mean
Standard
deviation
Minimum
value
Maximum
value
Group I (n = 12) 19.9 4.8 10.9 29.6 14.7 3.2 7.6 19.6
Group II (n = 18) 18.5 5.0 10.7 29.1 13.2 3.3 9.1 20.7
Group III (n = 17) 17.9 4.3 8.6 27.2 13.7 3.7 7.4 22.2
Group IV (n = 7) 16.9 5.8 9.7 23.9 12.5 4.0 7.1 16.9
p = 0.580 p = 0.538
ventilation (VEmax), ventilatory equivalents for oxygen 
(VEO2max) and for carbon dioxide (VECO2max).
Descriptive measures for the variables studied were 
calculated. To compare the four age groups in terms of 
anthropometric and cardiopulmonary variables, a single-
factor analysis of variance was performed14.
RESULTS
Body weight, height and body mass index for the four 
age groups were similar (Table I). 
No significant difference was found regarding 
functional cardiorespiratory limitation indices during 
exercise, maximal oxygen uptake (VO2max) and 
anaerobic threshold (AT), expressed in milliliters per 
kilogram of body weight, among the different groups of 
these patients (Table II). 
No signiﬁ cant differences were found among the 
following variables: VO2max l/min, VCO2max l/min, 
HRmax, and O2 pulse max among the different age 
groups (Table III).
No signiﬁ cant differences were found also among the 
following variables: VEmax, VEO2max, VECO2max, and 
Rmax among the groups of CHF patients (Table IV).
DISCUSSION
Maximal oxygen uptake and anaerobic threshold are 
important indices for CHF investigation and classiﬁ cation15.
In a study performed with healthy subjects, Barros Neto 
et al16, demonstrated that these indices decline with age, 
in men and women alike, sedentary or not. Therefore, 
we believe that in evaluating cardiorespiratory functional 
capacity of healthy subjects, not only gender and training 
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Table III – Descriptive measures and analysis of variance results for maximal oxygen uptake (VO2max), carbon 
dioxide production (VCO2max), heart rate (HRmax), and oxygen pulse (O2 pulse max) of groups I (30 to 39 
years), II (40 to 49 years), III (50 to 59 years), and IV (≥ 60 years) of patients with congestive heart failure
VO2max (l/min) VCO2max (l/min) HRmax (bpm) O2 pulse max (ml/bpm)
Mean Standard deviation Mean Standard deviation Mean Standard deviation Mean Standard deviation
Group I (n = 12) 1.27 0.40 1.37 0.41 141.2 27.1 9.2 3.1
Group II (n = 18) 1.26 0.40 1.40 0.47 140.6 21.7 9.1 2.9
Group III (n = 17) 1.22 0.40 1.34 0.43 141.2  22.6 8.7 3.0
Group IV (n = 7) 1.25 0.50 1.40 0.54 137.9 23.1 9.1 3.3
p = 0.984 p = 0.980 p = 0.990 p = 0.979
Table IV – Descriptive measures and analysis of variance results for maximal pulmonary ventilation (VEmax), 
ventilatory equivalents for oxygen (VEO2max) and for carbon dioxide (VECO2max), and respiratory exchange ratio 
(Rmax) for groups I (30 to 39 years), II (40 to 49 years), III (50 to 59 years) e IV (≥ 60 years) of 
patients with congestive heart failure
VEmax (l/min) VEO2max VECO2max Rmax
Mean St deviation Mean St deviation Mean S deviation Mean St deviation
Group I (n = 12)  61.0 22.3 50.5 10.4 45.3 8.5 1.12 0.08
Group II (n = 18)  62.9 16.7 54.2 14.4 47.7 11.2 1.13 0.11
Group III (n = 17)  58.6 16.9 51.1 10.2 45.1 7.7 1.14 0.12
Group IV (n = 7)  59.8 15.7 53.4 15.8 47.2 13.0 1.13 0.07
p = 0.914 p = 0.836 p = 0.853 p = 0.948
level should be considered, but also age. 
In this sample, however, the aerobic capacity of cardiac 
patients did not seem to be signiﬁ cantly affected by age, 
because, although mean VO2max and AT are numerically 
higher in the younger group, no signiﬁ cant differences 
were found among the groups, which might be explained 
by the great individual variation of each group. Indeed, in 
group I (30 to 39 years), the lowest VO2max and AT values 
were 10.9 ml/kg/min and 7.6 ml/kg/min, respectively, 
whereas in group IV (≥ 60 years), the highest VO2max
and AT values were 23.9 ml/kg/min and 16.9 ml/kg/min, 
respectively. Besides, VO2max and AT values in all groups 
were lower than those expected for the age in sedentary 
subjects16. These ﬁ ndings suggest that, in patients with 
heart failure, the main limiting factor for aerobic power is 
associated with intrinsic conditions of the heart disease 
itself, in all studied age groups.
We recognize that the small number of patients in each 
group is a limitation in this study. This is due to the fact 
that all tests included in the study were maximal, once 
those tests terminated by clinical criteria before the patient 
reached VO2max were excluded. Group IV comprised only 
seven patients, because most of them were candidates 
for cardiac transplant, and younger cardiac patients were 
given priority for this procedure. However, in spite of the 
number of patients, no signiﬁ cant differences regarding 
cardiopulmonary variables were observed, through 
variance analysis, among the age groups. 
We also recognize the lack of a healthy control 
group, stratiﬁ ed by age bracket, as another limitation 
of the study.
The different etiology of heart disease might not have 
affected the results of this study, since Yazbek Jr et al17
demonstrated that variables obtained by cardiopulmonary 
exercise testing do not differ among patients with 
ischemic, chagasic and idiopathic cardiomyopathy.
Maximal oxygen uptake8,16,18-21 and maximal carbon 
dioxide production8 decline with age in normal subjects. 
In our study, we found no differences in VO2max (l/min) 
and VCO2max (l/min) in cardiac patients of different ages, 
suggesting that heart disease may affect these variables 
regardless of age group. No significant differences 
are expected in maximal respiratory exchange ratio in 
subjects of different age group8,21, and the same behavior 
was found for Rmax in cardiac patients, showing that 
VO2max reduction is proportional to that of VCO2max in 
these patients.
Maximal heart rate8,18-21 and maximal oxygen 
pulse8,20,21 decline with age in healthy subjects. Weber 
et al6 found lower differences for O2 pulse max in more 
functionally compromised cardiac patients. Therefore, 
the lack of difference in maximal oxygen pulse among 
CHF groups seems to indicate that functional capacity of 
cardiac patients may be similarly affected in all studied 
age group. Nevertheless, maximal heart rate is one of the 
variables most affected by age, and we found no difference 
concerning this variable among the study age groups. We 
attributed this result to those patients who had cardiac 
pacemakers, were taking beta-blocker or were in atrial 
ﬁ brillation. Therefore, we cannot deﬁ nitely say that the 
similar HRmax in patients of different age groups was a 
result of the heart disease.
Maximal ventilation during exercise decreases with age 
in healthy subjects8,21, due to lower maximal workloads 
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reached and the less lactic acidosis tolerance by elderly 
subjects8. The similar VEmax found in all groups also seems 
to suggest a functional cardiorespiratory limitation associated 
with the heart disease in all age groups. In healthy subjects, 
a slight increase in VEO2max and VECO2max is expected with 
age, but in the cardiac patients studied these variables seem 
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not to change with age group. 
Concluding, the results suggest that cardiorespiratory 
functional capacity during exercise in CHF patients, 
as well as cardiopulmonary variables obtained during 
maximal exercise, may be similarly affected by the heart 
disease in all studied age group.
